The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review.

Alice Stewart, Josie Sandercock, Stirling Bryan, Christopher Hyde, Pelham Barton, Anne Fry-Smith, Amanda Burls

Research output: Contribution to journal › Article

29 Citations (Scopus)

Original language	English
Pages (from-to)	1-97
Number of pages	97
Journal	Health Technology Assessment
Volume	5
Issue number	2
Publication status	Published - 1 Jan 2001

Cite this

@article{9f8820344f3a4e998fa33e9f869b1671,

title = "The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review.",

author = "Alice Stewart and Josie Sandercock and Stirling Bryan and Christopher Hyde and Pelham Barton and Anne Fry-Smith and Amanda Burls",

year = "2001",

month = jan,

day = "1",

language = "English",

volume = "5",

pages = "1--97",

journal = "Health Technology Assessment",

issn = "2046-4924",

publisher = "NIHR Health Technology Assessment Programme",

number = "2",

}

TY - JOUR

T1 - The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review.

AU - Stewart, Alice

AU - Sandercock, Josie

AU - Bryan, Stirling

AU - Hyde, Christopher

AU - Barton, Pelham

AU - Fry-Smith, Anne

AU - Burls, Amanda

PY - 2001/1/1

Y1 - 2001/1/1

M3 - Article

C2 - 11809124

SN - 2046-4924

VL - 5

SP - 1

EP - 97

JO - Health Technology Assessment

JF - Health Technology Assessment

IS - 2

ER -